Important Information
Disclosures & Regulatory Information
These disclosures describe what Stem Nova Direct is, what it is not, and the regulatory context for everything discussed on this site. Please read them alongside any individual page.
Our role
The information on this site is educational only and is not a substitute for primary or specialist medical care. It is not medical advice. Decisions about whether any regenerative option is appropriate are made by a licensed clinician in our network.
Regulatory status
These products are not FDA-approved to diagnose, treat, cure, or prevent any disease.
The MSC product discussed on this site is not FDA-approved to diagnose, treat, cure, or prevent disease. A licensed clinician evaluates the individual, discusses potential risks, limitations and alternatives, and determines whether any option is appropriate.
Exosomes on Stem Nova Direct are offered strictly as topical cosmetic ingredients intended to support the appearance of skin — tone, texture, and a healthy-looking glow. They are not a treatment, are not injected, and are not intended to affect any body function, disease, or condition.
FDA registration of the source lab
An FDA-registered tissue establishment is a facility that has listed itself with the FDA and handles human cells and tissue under Current Good Tissue Practices (cGTP) — the standards in 21 CFR Part 1271 intended to prevent the introduction, transmission, and spread of communicable disease.
FDA registration of the source lab pertains to facility and manufacturing standards only and does not constitute FDA approval of any product for any specific use.
Tissue sourcing
Umbilical cord tissue source from AATB-accredited establishment with this tissue category within scope of accreditation.
Testimonials & endorsements
Testimonials reflect individual experiences and are not a guarantee of any result. Where a person has a material connection to Stem Nova Direct — including compensation or affiliation — that connection is disclosed. Disclosures are made in accordance with the FTC Guides, 16 CFR Part 255.
References to public figures or their stories are for illustration only and do not imply endorsement of Stem Nova Direct or any product.
Medical oversight
Dr. Clay Buchanan, MD, serves as Medical Director for Stem Nova Direct, providing platform-level medical oversight for our education, screening, and referral framework. Individual clinical evaluations and care decisions are made by the licensed clinicians who directly evaluate each patient.